These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23324394)

  • 21. Ras activity regulates cyclin E degradation by the Fbw7 pathway.
    Minella AC; Welcker M; Clurman BE
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9649-54. PubMed ID: 15980150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.
    Rodríguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L
    Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
    Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G
    Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression.
    Mao L; Ding J; Perdue A; Yang L; Zha Y; Ren M; Huang S; Cui H; Ding HF
    Oncogene; 2012 Aug; 31(33):3785-95. PubMed ID: 22120721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cx43 and AKAP95 regulate G1/S conversion by competitively binding to cyclin E1/E2 in lung cancer cells.
    Chen R; Chen Y; Yuan Y; Zou X; Sun Q; Lin H; Chen X; Liu M; Deng Z; Yao Y; Guo D; Zhang Y
    Thorac Cancer; 2020 Jun; 11(6):1594-1602. PubMed ID: 32338437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
    Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
    Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.
    Tron AE; Arai T; Duda DM; Kuwabara H; Olszewski JL; Fujiwara Y; Bahamon BN; Signoretti S; Schulman BA; DeCaprio JA
    Mol Cell; 2012 Apr; 46(1):67-78. PubMed ID: 22405651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated view of cyclin E function and regulation.
    Siu KT; Rosner MR; Minella AC
    Cell Cycle; 2012 Jan; 11(1):57-64. PubMed ID: 22186781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase.
    Grim JE; Gustafson MP; Hirata RK; Hagar AC; Swanger J; Welcker M; Hwang HC; Ericsson J; Russell DW; Clurman BE
    J Cell Biol; 2008 Jun; 181(6):913-20. PubMed ID: 18559665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.
    Ou B; Zhao J; Guan S; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Zheng M; Feng H; Lu A
    Cancer Lett; 2016 Oct; 380(2):457-466. PubMed ID: 27423313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in regulation and function of E-cyclins in human cancer cells.
    Geng Y; Sicinski P
    Cell Cycle; 2013 Apr; 12(8):1165. PubMed ID: 23549169
    [No Abstract]   [Full Text] [Related]  

  • 32. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
    Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
    Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PARK2 suppresses the proliferation of high-grade serous ovarian carcinoma via inducing the proteasomal degradation of ZNF703.
    Wang F; Li Y; Han Y; Zhang Y; Wang H; Wang L; Wang C; Guo M; Li P
    Med Oncol; 2024 Jul; 41(8):207. PubMed ID: 39043895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
    Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H
    J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
    Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
    Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A C-terminal fragment of Cyclin E, generated by caspase-mediated cleavage, is degraded in the absence of a recognizable phosphodegron.
    Plesca D; Mazumder S; Gama V; Matsuyama S; Almasan A
    J Biol Chem; 2008 Nov; 283(45):30796-803. PubMed ID: 18784078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYC is a critical target of FBXW7.
    Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
    Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F-box protein specificity for g1 cyclins is dictated by subcellular localization.
    Landry BD; Doyle JP; Toczyski DP; Benanti JA
    PLoS Genet; 2012; 8(7):e1002851. PubMed ID: 22844257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53.
    Kimura T; Gotoh M; Nakamura Y; Arakawa H
    Cancer Sci; 2003 May; 94(5):431-6. PubMed ID: 12824889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The PP2A-B56 Phosphatase Opposes Cyclin E Autocatalytic Degradation via Site-Specific Dephosphorylation.
    Davis RJ; Swanger J; Hughes BT; Clurman BE
    Mol Cell Biol; 2017 Apr; 37(8):. PubMed ID: 28137908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.